FDA Drug recall D-231-2013
NOOTROPA COGNITIVE ENHANCEMENT SUPPLEMENT, 400 mg Aniracetam Capsules 60 count bottle, OTC Manufactured & Packaged in the USA for NOOTROPA.…
- FDA Drug
- Class II
- terminated
- Published 2013-04-10
On 2013-04-10 the FDA classified a Class II recall of NOOTROPA COGNITIVE ENHANCEMENT SUPPLEMENT, 400 mg Aniracetam Capsules 60 count bottle, OTC Manufactured & Packaged in the USA for NOOTROPA.… by Palmer Natural Products, citing marketed Without an Approved NDA/ANDA: The products are unapproved drugs.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-231-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-03-11 |
| Published | 2013-04-10 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Palmer Natural Products |
| Distribution | CA, FL, ID |
Product
NOOTROPA COGNITIVE ENHANCEMENT SUPPLEMENT, 400 mg Aniracetam Capsules 60 count bottle, OTC Manufactured & Packaged in the USA for NOOTROPA.COM. DEVELOPED BY: Digital Superfuture Limited Arntel Building 9B 148 Des Voeux Rd. Hong Kong.
Reason
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Identifiers
| code_info | Lot HJLA, |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-231-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.